-
Signature
-
/s/ Aimee Weast by Aimee Weast, Attorney in Fact for Michael D. Sicilia (POA filed 6/12/2025)
-
Stock symbol
-
ORCL
-
Transactions as of
-
Sep 15, 2025
-
Transactions value $
-
-$12,560,133
-
Form type
-
4
-
Date filed
-
9/17/2025, 08:35 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Sicilia Michael D. |
President, Industries |
C/O DELPHI ASSET MGMT CORPORATION, 200S.VIRGINIA ST., SUITE 625, RENO |
/s/ Aimee Weast by Aimee Weast, Attorney in Fact for Michael D. Sicilia (POA filed 6/12/2025) |
2025-09-17 |
0002071965 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ORCL |
Common Stock |
Options Exercise |
$0 |
+52.7K |
+53.09% |
$0.00 |
152K |
Sep 15, 2025 |
Direct |
|
| transaction |
ORCL |
Common Stock |
Tax liability |
-$7.44M |
-25.5K |
-16.77% |
$292.18 |
126K |
Sep 15, 2025 |
Direct |
F1 |
| transaction |
ORCL |
Common Stock |
Sale |
-$5.12M |
-16.3K |
-12.91% |
$313.60 |
110K |
Sep 16, 2025 |
Direct |
|
| holding |
ORCL |
Common Stock |
|
|
|
|
|
2.66K |
Sep 15, 2025 |
By Spouse |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ORCL |
Restricted Stock Unit |
Options Exercise |
$0 |
-52.7K |
-33.33% |
$0.00 |
105K |
Sep 15, 2025 |
Common Stock |
52.7K |
|
Direct |
F2, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: